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Abstract
Growth/differentiation factor 11 (Gdf11) is a transforming growth factor  family member previously shown to control anterior/posterior
patterning of the axial skeleton. We now report that Gdf11 also regulates kidney organogenesis. Mice carrying a targeted deletion of Gdf11
possess a spectrum of renal abnormalities with the majority of mutant animals lacking both kidneys. Histological analysis revealed a failure
in ureteric bud formation at the initial stage of metanephric development in most Gdf11 mutant embryos examined. The metanephric
mesenchyme of mutant embryos lacking a ureteric bud was found to be defective in the expression of glial cell line-derived neurotrophic
factor (Gdnf), a gene known to direct ureteric bud outgrowth. The addition of Gdnf protein to urogenital tracts taken from Gdf11 null
embryos induced ectopic ureteric bud formation along the Wolffian duct. Our studies suggest that Gdf11 may be important in directing the
initial outgrowth of the ureteric bud from the Wolffian duct by controlling the expression of Gdnf in the metanephric mesenchyme.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Kidney organogenesis is a highly organized and complex
process (Grobstein, 1955; Saxen, 1987). In mammals, kid-
ney development occurs in three stages. At embryonic stage
day 8 (E8) in mice, the pronephros, comprised of a pro-
nephric duct and tubules, differentiates from intermediate
mesoderm in the anterior region of the embryo. The meso-
nephros appears at E9.5 when the pronephric duct (Wolffian
duct) extends caudally to the cloaca and induces the adja-
cent mesonephric mesenchyme to condense and form a
linear array of nephric tubules. Both the pro- and mesone-
phros regress shortly after their formation. The third stage of
kidney development begins with the formation of the de-
finitive kidney, the metanephros (E11). The initiation of
metanephric development occurs when an epithelial bud
grows out from the posterior region of the Wolffian duct and
invades the loose metanephric mesenchyme. Bidirectional
inductive interactions between the ductal epithelium and the
nephrogenic mesenchyme result in the specification of dis-
tinct nephric cell types and the spatial organization of the
kidney. Signals from the ureteric bud promote both the
survival of the metanephric mesenchyme and the induction
of the surrounding metanephric mesenchyme to condense
and differentiate into tubular structures, which will later
form the nephrons of the kidney. The metanephric mesen-
chyme, in turn, sends signals out to the ureteric bud, which
will induce the ureteric epithelium to grow and branch into
the metanephric mesenchyme. The ureteric branches will
ultimately form the collecting duct system of the kidney.
A number of secreted molecules have been shown to
signal between the ureteric bud and the metanephric mes-
enchyme in order to control the coordinated development of
the definitive kidney (Kuure et al., 2000; Schedl and Hastie,
2000; Davies, 2001). Glial cell line-derived neurotrophic
factor (Gdnf) directs the first stage of metanephric develop-
ment, the outgrowth of a ureteric bud from the Wolffian
duct. Gdnf is secreted from the metanephric mesenchyme
and binds to its receptor, Ret receptor tyrosine kinase
(c-Ret), and the coreceptor, glycosylphosphatidyl-inositol-
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linked Gdnf family receptor 1 (Gfr1), which are highly
expressed in the posterior portion of the Wolffian duct, to
induce ureteric bud formation (Pachnis, 1993; Durbec et al.,
1996; Jing et al., 1996; Treanor et al., 1996). The majority
of mice carrying a targeted deletion for Gdnf, c-Ret, or
Gfr1 exhibit a complete failure in ureteric bud formation
(Schuchardt et al., 1994, 1996; Moore et al., 1996; Pichel et
al., 1996; Sanchez et al., 1996; Enomoto et al., 1998). In
addition to these data, Gdnf has been shown in vitro to be
capable of inducing ectopic ureteric bud formation along
various portions of the Wolffian duct and directing the
growth of these buds toward a localized source (Pepicelli et
al., 1997; Sainio et al., 1997), further supporting the impor-
tance of Gdnf in controlling ureteric bud outgrowth.
The Gdnf/c-Ret/Gfr1 signaling pathway is also essen-
tial in subsequent stages of kidney development. Gdnf di-
rects the continued growth and branching of the ureteric bud
into the surrounding metanephric mesenchyme by binding
to its receptors on the tips of the ureteric branches. Gdnf
protein has been shown to increase the number of ureteric
branches and the amount of cell proliferation in the ureteric
branching tips when added to kidney rudiments in culture
(Vega et al., 1996; Pepicelli et al., 1997; Sainio et al., 1997).
Exogenously added Gdnf protein has also been shown to
increase the transcription of its own receptor, c-Ret, and
Wnt11 at the tips of the ureteric branches (Pepicelli et al.,
1997). Thus, the Gdnf/c-Ret/Gfr1 signaling pathway is
important in the formation of the ureteric bud at the initial
stage of metanephric development but is also needed at later
stages to control the development of the ureteric tree.
In this paper, we describe the role of a secreted protein,
growth/differentiation factor 11 (Gdf11), that appears to
work upstream of the Gdnf/c-Ret/Gfr1 signaling pathway
in order to regulate mammalian kidney organogenesis.
Gdf11 is a member of the transforming growth factor 
(TGF) family of growth and differentiation factors and is
closely related to myostatin (McPherron et al., 1997). At
early stages of embryonic development, Gdf11 is expressed
at highest levels in the primitive streak region and in the tail
bud. At later stages, Gdf11 is widely expressed in a variety
of tissues, including the neural tube, the dorsal root gan-
glion, the retina, and the limb bud (Gamer et al., 1999;
McPherron et al., 1999; Nakashima et al., 1999). Previ-
ously, we described the generation of mice carrying a tar-
geted deletion of Gdf11 (McPherron et al., 1999). We
showed that homozygous null mice for Gdf11 have dramatic
homeotic transformations of the axial skeleton, suggesting
that Gdf11 is essential for the proper specification of posi-
tional identity. Here, we report that Gdf11 also plays an
important role during kidney development. Our findings
indicate that Gdf11 may direct the initiation of metanephric
kidney development by controlling the expression of Gdnf
in the metanephric mesenchyme and thereby inducing ure-
teric bud outgrowth. Gdf11 is the earliest acting secreted
factor identified to date that specifically directs the forma-
tion of the definitive kidney, the metanephros.
Materials and methods
Generation of Gdf11 mutant mice
Gdf11 mutant mice were previously described (McPher-
ron et al., 1999), and the genotypes of the mice or embryos
were determined on tail or yolk sac extracts by Southern
blot analysis (McPherron et al., 1999). Mice were housed in
the Johns Hopkins University School of Medicine Animal
Facility under the guidelines for animal experimentation
held by the School of Medicine.
Histological and in situ analysis
Mice heterozygous for Gdf11 were crossed, and the re-
sulting embryos were collected in phosphate-buffered saline
(PBS) and fixed in 4% paraformaldehyde overnight. The
fixed embryos were then soaked in 0.5 M sucrose/PBS,
embedded in O.C.T. compound (Tissue-Tek), and frozen.
Samples were sectioned at 12 m thickness with a mic-
rotome cryostat. Sections for histological analysis were
stained with hematoxylin and eosin.
In situ hybridization analysis was performed by using
digoxigenin-labeled riboprobes (UTP/DIG, Roche) on fro-
zen sections as described (Wilkinson, 1992), with blocking
and antibody incubation steps as described in Heller et al.
(1998). Slides were mounted in a water-based medium
(Aquamount) and photographed. Both sense and antisense
riboprobes for each gene were used in each set of experi-
ments. The riboprobes used for the Gdf11 transcript corre-
sponded only to the pro-region and the 3 UTR in order to
avoid cross-hybridization to myostatin. Probes correspond-
ing to c-Ret, Eya1, Emx2, Gdnf, Lim1, and Six2 were gen-
erated by PCR using primers based on the published se-
quences from GenBank. The probe for WT1 was obtained
from the American Type Culture Collection (ATCC). The
Pax2 and ActRIIB probes were kindly provided by G.
Dressler (University of Michigan, Ann Arbor) and J. Mas-
sague (Memorial Sloan-Kettering Cancer Center, New
York), respectively.
TUNEL analysis
DNA nick-end labeling of tissue sections was carried out
according to published procedures (Gavrieli et al., 1992) using
digoxigenin-labeled 11-2, 3 ddUTP (Roche) on frozen sec-
tions as described (Wilkinson, 1992), with blocking and anti-
body incubation steps as described in Heller et al. (1998).
Explant cultures
Metanephric kidney rudiments were dissected from
E11.5 mouse embryos in Leibovitz L-15 medium (Gibco,
Invitrogen Corporation) supplemented with 1% fetal bovine
serum (FBS), 2 mM glutamine, 100 U/ml penicillin, and
100 U/ml streptomycin. Cultures were placed on nucleopore
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membranes (Whatman) of 0.1-m pore size and cultivated
in a transwell system containing F12/DMEM medium
(Gibco) with 10% FBS, 4 mM glutamine, 100 U/ml peni-
cillin, and 100 U/ml streptomycin. Cultures were grown at
37°C in 5% CO2 for up to 96 h, with a change of medium
each day, and were evaluated under a phase-contrast micro-
scope. Photographs were taken every 24 h in culture. Gdf11
mutant embryos could be readily distinguished from their
wild type or heterozygous littermates based on their axial
skeletal abnormalities at the time of dissection, but in all
Fig. 1. Renal defects in mice lacking Gdf11. (A–C) Urogenital tracts of Gdf11/, Gdf11/ and Gdf11/ newborn male (A) and female (B, C) mice. Note
the absence of kidneys and ureters bilaterally (A, B) or unilaterally (C). (D–Q) Hematoxylin and eosin (H&E)-stained transverse sections of wild type (D,
F, H, J, L, N, and P) and Gdf11 mutant (E, G, I, K, M, O, and Q) mice. (D, E) Normal development of mesonephric tubules (arrows) in both Gdf11/ and
Gdf11/ E10.5 embryos. The formation of the metanephric mesenchyme and the posterior extension of the Wolffian duct (arrowhead) for a Gdf11/ E10.5
embryo in (G) resembled that of a wild type E10.5 embryo (F). Absence of ureteric bud formation in an E11.5 Gdf11/ embryo is shown in (I). (K) Complete
absence of kidney tissue (arrowhead) in an E12.5 Gdf11 mutant embryo. (M, O) An E14.5 Gdf11/ embryo with unilateral kidney development. (N, O)
Higher magnifications of (L) and (M) respectively. The newborn kidney shown in (Q) was taken from a Gdf11/ animal that exhibited unilateral kidney
formation and was found to be underdeveloped when compared with a kidney taken from a wild type littermate (P). Abbreviations: a, adrenal gland; b,
bladder; g, gonad; k, kidney; m, metanephric mesenchyme; mt, mesonephric tubules; o, ovary; t, testis; u, ureter; ub, ureteric bud; ut, uterus; wd, Wolffian
duct. The scale bars represent 200 m. (D–G) Taken at the same magnification.
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cases the genotypes were later confirmed by using Southern
blot analysis.
For the Gdnf experiments, entire urogenital tracts, con-
sisting of the Wolffian duct and both the mesonephros and
metanephros regions, were dissected from E11.5 wild type
or Gdf11 mutant embryos and grown in the presence or
absence of Gdnf protein (50 ng/ml; recombinant rat Gdnf;
R&D Systems).
For the recombination experiments, epithelial and mes-
enchymal components of the E11.5 kidney rudiments were
isolated by incubating the rudiments on ice for 6 min with
0.25% trypsin/EDTA (Gibco) and then separated by me-
chanical manipulation using 27-gauge needles. The tubulo-
genesis assays used wild type or Gdf11 mutant spinal cord
cultured next to wild type or Gdf11 mutant separated met-
anephric mesenchyme. Spinal cord taken from E11.5 em-
bryos was obtained from the cervical regions and dissected
free from surrounding tissues and ganglia.
Immunofluorescence staining
Kidney explants were removed from culture at desired time
points and then fixed and stored in methanol at20°C. Kidney
explants were prepared for whole-mount immunostaining by
washing the cultures in phosphate-buffered saline, 0.1%
Tween (PBT), and 10% sheep serum for several hours. The
explants were then incubated overnight at 4°C in PBT, 1%
sheep serum, and a polyclonal rabbit anti-EHS laminin (Sig-
ma) that recognizes the epithelialized nephrons of the kidney
(Ekblom et al., 1980). The explants were then washed in PBT
and incubated for 4 h at room temperature in PBT, 1% sheep
serum, and rhodamine-conjugated secondary antibodies (Santa
Cruz Laboratories). Explants were washed with PBT and
mounted on slides with a water-based medium (Aquamount).
Similar procedures were followed for explants stained with
fluorescein-conjugated Dolichos biflorus-agglutinin (DBA)
(Vector Laboratories) to visualize the Wolffian duct system
and the ureteric tree (Laitinen et al., 1987).
Results
Kidney defects in mice lacking Gdf11
Mice homozygous for a targeted deletion in the Gdf11
gene died within 1 day after birth (McPherron et al., 1999).
Fig. 2. Expression of Gdf11 and ActRIIB during normal kidney organogenesis. Transverse sections from wild type embryos at E10.5 (A, B, F, G, K, and L),
E11.5 (C, H, and M), E12.5 (D, I, and N), and E14.5 (E, J, and O) were analyzed by in situ hybridization for the expression patterns of Gdf11 (A–E), ActRIIB
(F–J), and the kidney marker gene, Pax2 (K–O). (A, B) Gdf11 was expressed at E10.5 in the mesonephric tubules, the Wolffian duct, and at lower levels
in the metanephric mesenchyme. Gdf11 mRNA was detected in both the metanephric mesenchyme and the ureteric bud at E11.5 (C). At E12.5, Gdf11 was
expressed in the developing ureter, the ureteric branches, as well as in a population of uninduced metanephric mesenchyme (m) in the periphery of the
developing kidney (D). Lower levels of Gdf11 expression could be detected in the condensed metanephric mesenchyme at this stage. Gdf11 continued to be
expressed in the ureter, ureteric branches, and condensed metanephric mesenchyme at E14.5 (E). Expression for ActRIIB, a potential receptor for Gdf11, was
also detected in the mesonephric kidney, the Wolffian duct, and at low levels in the metanephric mesenchyme at E10.5 (F, G). ActRIIB expression was later
detected in both the metanephric mesenchyme and the ureteric bud at E11.5 (H), and continued to be expressed in these mesenchymal and epithelial
derivatives at E12.5 (I) and E14.5 (J). The kidney marker gene, Pax2, was also expressed in the mesonephros, the Wolffian duct, the ureteric bud, the
metanephric mesenchyme, and their derivatives within the developing kidney (K–O). Abbreviations: cm, condensed metanephric mesenchyme; m,
metanephric mesenchyme; mt, mesonephric tubules; u, ureter; ub, ureteric bud; wd, Wolffian duct. The scale bars represent 200 m. All panels were taken
at the same magnification shown in (A), with the exception of (E) (L), and (O).
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In the course of investigating the cause of death in these
animals, we noted that nearly all mutant mice had kidney
defects that were evident on gross examination of the inter-
nal organs. Gdf11 mutant mice showed a wide spectrum of
kidney defects, with the majority of mutants (28 out of 47
examined) showing complete bilateral renal agenesis. Most
of the remaining mutants exhibited milder kidney defects
ranging from unilateral agenesis (12 out of 47 examined) to
smaller sized kidneys on one or both sides. Unilateral renal
agenesis was also observed in a small percentage of het-
erozygous mice (5 out of 93 examined). Dissection of the
urogenital tracts showed that all animals lacking a kidney on
one or both sides also exhibited loss of the corresponding
ureter. However, regardless of the presence or absence of
kidneys in these mice, the adrenal glands, male and female
reproductive tracts, and bladder appeared normal in both
their placement and structure (Fig. 1A–C).
In order to determine the stage at which abnormal kidney
development first becomes apparent in Gdf11 mutant em-
bryos, we analyzed the kidneys at various times during
embryonic development. Histological examination revealed
that the formation of the intermediate kidney, the mesone-
phros, appeared grossly normal at E10.5 in Gdf11 mutant
mice (Fig. 1D and E). We also noted that the Wolffian duct
had extended posteriorly and the metanephric mesenchyme
had formed in these E10.5 mutant embryos (5/5) in a similar
fashion as their wild type littermates (Fig. 1F and G).
Defects were first observed at E11.5, when metanephric
kidney development is initiated. At this stage, the wild type
ureteric bud has grown out from the Wolffian duct and
invaded the metanephric mesenchyme (Fig. 1H). In the
majority of Gdf11 mutant mice observed (17/23), the ure-
teric bud failed to form and branch into the metanephric
mesenchyme, although the Wolffian duct was clearly
present (Fig. 1I). A small number of mutant animals showed
normal uni- or bilateral ureteric bud formation at this stage
(6/23) (data not shown). By E12.5 in wild type embryos, the
ureteric bud has branched extensively into the metanephric
mesenchyme, and the metanephric mesenchyme has begun
to condense around the ureteric tips and differentiate into
epithelial nephron-like structures (Fig. 1J). In most E12.5
Gdf11 mutant embryos analyzed (13/14), these structures
were absent in the area where the kidney should have
developed (Fig. 1K).
In wild type mice, metanephric development is well
established by E14.5, as pretubular structures have begun to
differentiate into nephrons, and a collecting duct system has
started to form (Fig. 1L and N). Analysis of embryos null
for Gdf11 at E14.5 revealed complete absence of kidney
structures either bilaterally (4/7) (data not shown) or unilat-
erally (3/7) (Fig. 1M and O). Kidney tissue that was present
in mutant embryos at this stage sometimes appeared under-
developed but was histologically normal. Kidneys isolated
from newborn Gdf11 mutant mice that showed unilateral
renal development were also analyzed and compared with
their wild type littermates (Fig. 1P and Q). Although the
mutant kidneys were abnormally small in size and pos-
sessed a reduced number of nephrons, histological exami-
nation revealed that these kidneys were normal in their
overall architecture (Fig. 1Q). Hence, in the absence of
Gdf11, initiation of metanephric development was severely
impaired because a ureteric bud failed to form in the pos-
terior region of the Wolffian duct. However, in a subset of
mutant embryos in which kidney development did occur, it
appeared to progress in a normal fashion.
Gdf11 expression in wild type embryos throughout kidney
organogenesis
To assess if the normal mRNA expression patterns for
Gdf11 correlate with the timing of the kidney defects ob-
served in mice null for this gene, in situ analysis using
digoxigenin-labeled riboprobes corresponding to Gdf11 was
done at several time points throughout kidney organogene-
sis in wild type embryos. Gdf11 was expressed in the meso-
nephric tubule system, which is well established at E10.5
(Fig. 2A). Gdf11 mRNA was also present in the Wolffian
duct and at low levels in the metanephric mesenchyme that
had not yet been invaded by a ureteric bud in E10.5 wild
type embryos (Fig. 2B). During the initial stage of meta-
nephric development at E11.5, Gdf11 was found to be
expressed both in the metanephric mesenchyme and in the
invading ureteric bud epithelium that had grown off the
posterior region of the Wolffian duct (Fig. 2C). At E12.5,
Gdf11 was expressed in the ureter and the ureteric branches
of the developing kidney and in a population of uninduced
metanephric mesenchyme within the renal cortex (Fig. 2D).
Gdf11 mRNA could also be detected at low levels in the
condensed metanephric mesenchyme at this stage. By
E14.5, when metanephric development is well established,
Gdf11 continued to be expressed in the ureter and ureteric
branches, in the uninduced metanephric mesenchyme
within the periphery of the kidney, and in the condensed
metanephric mesenchyme differentiating into nephrons
(Fig. 2E). A comparison of the expression patterns for
Gdf11 and Pax2, a kidney marker which is known to be
expressed in both the epithelial and mesenchymal renal
lineages (Figs. 2K-2O; Dressler et al., 1990), showed that,
although Gdf11 and Pax2 mRNA were both expressed in
the ureteric bud, the metanephric mesenchyme, and their
derivatives, Gdf11 appeared to be expressed at lower levels
in the condensing metanephric mesenchyme and developing
nephrons. In addition, Gdf11 mRNA was detected in the
uninduced metanephric mesenchyme within the kidney pe-
riphery at E12.5 and E14.5, which was a region devoid of
Pax2 expression. In situ analysis of sections from newborn
kidneys showed decreased Gdf11 expression at this stage,
but low levels of expression could be detected in the glo-
meruli, distal tubules, and collecting ducts (data not shown).
In summary, wild type Gdf11 mRNA expression was de-
tected in both the ureteric and mesenchymal derivatives
throughout metanephric development. These expression
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patterns correlated with the timing of the renal defects
observed in the Gdf11 mutant embryos.
Expression of kidney marker genes in E11.5 Gdf11
homozygous mutant embryos
Histological studies had shown that the majority of E11.5
Gdf11 homozygous mutant embryos showed a complete
absence of ureteric bud invasion into the metanephric mes-
enchyme (Fig. 3A and B). In order to determine whether the
renal tissue observed in these Gdf11 null embryos had
formed and differentiated properly, the expression patterns
of several kidney marker genes previously reported to be
expressed at the earliest stages of metanephric development
were analyzed by using in situ hybridization. We examined
the expression of mRNAs encoding the receptor tyrosine
kinase, c-Ret, and the transcription factors Emx2, Lim1, and
Pax2, which are normally expressed in the Wolffian duct
and in the ureteric bud of wild type embryos at E11.5 (Fig.
3C, E, G, and I; Dressler et al., 1990; Pachnis et al., 1993;
Avantaggiato et al., 1994; Shawlot and Behringer, 1995;
Miyamoto et al., 1997). As shown in Fig. 3D, F, H, and J,
all of these genes were expressed in the Wolffian duct in
mice null for Gdf11 at E11.5, confirming that the Wolffian
duct had extended posteriorly in the mutant embryos. How-
ever, we were unable to detect expression of these genes in
the region in or near the metenephric mesenchyme, consis-
tent with the absence of ureteric bud invasion in the major-
ity of E11.5 mutant embryos examined. We also examined
the expression of the transcription factors Pax2, Eya1, Six2,
and WT1, which are normally expressed in the metanephric
mesenchyme before the initial invasion of the ureteric bud
and continue to be expressed in the induced metanephric
mesenchyme (Fig. 3I, K, M, and O; Dressler et al., 1990;
Pritchard-Jones et al., 1990; Pelletier et al., 1991; Arm-
strong et al., 1992; Oliver et al., 1995; Donovan et al., 1999;
Xu et al., 1999; Brophy et al., 2001). As shown in Fig. 3J,
L, N, and P, Pax2, Eya1, Six2, and WT1 mRNA were
appropriately expressed in the uninvaded metanephric mes-
enchyme of Gdf11 homozygous null embryos at E11.5,
suggesting that the metanephric mesenchyme had formed
and differentiated toward a nephric lineage.
Although these results confirm that both the Wolffian
duct and the metanephric mesenchyme had formed at E11.5
in Gdf11 homozygous mutant embryos, expression of met-
anephric mesenchyme markers was not completely normal.
Specifically, expression of Gdnf, which is normally present
in the metanephric mesenchyme (Fig. 3Q; Pichel et al.,
1996; Sanchez et al., 1996; Towers et al., 1998), was not
detected in any mutant Gdf11 embryo (9 out of 9 examined)
that failed to form a ureteric bud (Fig. 3R). Given that Gdnf
is known to be essential for the initiation of ureteric bud
outgrowth from the Wolffian duct, our expression studies
suggest that the failure of ureteric bud formation in Gdf11
mutant embryos may be a direct result of the lack of Gdnf
expression and that a primary role for Gdf11 in kidney
development is to induce expression of Gdnf in the meta-
nephric mesenchyme. Notably, those E11.5 Gdf11 defective
embryos (6 out of 6 examined) that possessed uni- or bilat-
eral invasion of the ureteric bud into the metanephric mes-
enchyme did show appropriate expression of Gdnf in the
invaded nephric mesenchyme (data not shown). Thus, there
may be another factor or cell signaling pathway redundant
with Gdf11 that allows for the proper expression of Gdnf in
the mutant metanephric mesenchyme and therefore rescue
of ureteric bud formation in a minority of Gdf11 mutants.
TUNEL analysis during early stages of kidney
development in Gdf11 mutant embryos
Our expression studies confirmed that, at E11.5, the
metanephric mesenchyme was present in Gdf11 null em-
bryos regardless of the presence or absence of ureteric bud
formation (Fig. 3). However, our histological analysis
showed that, by E12.5, the majority of Gdf11 mutant em-
bryos completely lacked renal tissue in the area where
kidney development should have occurred (Fig. 1K). In
order to determine the fate of the uninvaded metanephric
mesenchyme noted in the majority of mutant embryos at
E11.5, transverse sections were analyzed by in situ hybrid-
ization at the level of the developing gonads in E12.5
mutant embryos in the area where kidney organogenesis
was clearly underway in wild type littermates using kidney
markers expressed in the nephric mesenchyme (Eya1, Gdnf,
and WT1; Pritchard-Jones et al., 1990; Pelletier et al., 1991;
Armstrong et al., 1992; Pichel et al., 1996; Sanchez et al.,
1996; Towers et al., 1998; Donovan et al., 1999; Xu et al.,
1999), the ureteric branches (c-Ret; Pachnis et al., 1993;
Avantaggiato et al., 1994), or both derivatives (Pax2;
Dressler et al., 1990). None of the genes known to be
expressed in the developing kidney (c-Ret, Eya1, Gdnf,
Pax2, and WT1) were detected in E12.5 Gdf11 mutant
embryos in the region where the kidney would normally
reside at the level of the developing gonads (data not
shown). Therefore, the metanephric mesenchyme that was
observed in Gdf11 mutant embryos lacking ureteric bud
formation at E11.5 was not detected a day later at E12.5 in
most Gdf11 mutants in the area where kidney development
should have taken place.
In order to determine whether loss of kidney tissue oc-
curred through an apoptotic mechanism during these early
stages in Gdf11 null embryos, we carried out TUNEL anal-
ysis on transverse sections taken from wild type and mutant
embryos. There was no apoptosis detected in the metaneph-
ric mesenchyme of E11.5 Gdf11 mutant embryos that failed
to form a ureteric bud when compared with wild type
embryos (Fig. 4A–D). Similarly, we did not detect an in-
crease in TUNEL staining in E12.5 mutant embryos at the
level of the developing gonads in the region where the
kidneys are clearly present in wild type embryos (Fig.
4E–H). However, examination of sections taken from re-
gions of E12.5 mutant embryos just posterior to the devel-
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oping gonads revealed extensive apoptosis in the metaneph-
ric mesenchyme that had not been invaded by a ureteric bud
(Fig. 4I and J). The expression of metanephric mesenchy-
mal-specific genes (Eya1, Pax2, WT1) in this area confirmed
the identity of this tissue (Fig. 4K–M). These results suggest
that metanephric mesenchyme that is not invaded by a ureteric
bud at the beginning of kidney development in mutant em-
bryos undergoes programmed cell death around E12.5.
In vitro explant cultures of E11.5 Gdf11 null metanephric
rudiments
In order to examine renal development more closely in
Gdf11 null embryos undergoing uni- or bilateral kidney
formation, we observed the growth and differentiation of
whole E11.5 metanephric rudiments using explant cultures.
These explants were grown for 120 h on nucleopore filter
rafts and then stained with fluorescein-conjugated Dolichos
biflorus–agglutinin (DBA) to visualize the ureteric tree by
immunofluorescence. Explant cultures of kidney rudiments
taken from Gdf11 null embryos in which the ureteric bud
had clearly invaded the metanephric mesenchyme showed
extensive ureteric bud branching and nephric tubule forma-
tion comparable to rudiments taken from heterozygote lit-
termates (Fig. 5A and B). However, metanephric rudiments
taken from Gdf11 null embryos that were devoid of ureteric
bud formation did not differentiate in culture (Fig. 5C).
Instead, the mutant metanephric mesenchyme in these cul-
tures degenerated within 48 h presumably because the ure-
teric bud normally provides survival factors to the meta-
nephric mesenchyme at this stage (Saxen, 1987; Koseki et
al., 1992).
Fig. 3. Kidney marker expression in Gdf11 homozygous mutant embryos at E11.5. Sections for histological analysis in (A) and (B) were stained with
hematoxylin and eosin (H&E). Transverse sections were taken from E11.5 wild type (A, C, E, G, I, K, M, O, Q, and S) and Gdf11 mutant embryos lacking
a ureteric bud (B, D, F, H, J, L, N, P, R, and T) and analyzed for the expression of c-Ret (C, D), Emx2 (E, F), and Lim1 (G, H) in the Wolffian duct and
the ureteric bud; Pax2 (I, J) in both the epithelial and mesenchymal derivatives; and Eya1 (K, L), Six2 (M, N), WT1 (O, P), and Gdnf (Q, R) in the metanephric
mesenchyme by in situ hybridization. Note that Gdnf expression was not detected in the metanephric mesenchyme of any Gdf11/ embryo that failed to
form a ureteric bud (R). ActRIIB, a potential receptor for Gdf11, was expressed in the metanephric mesenchyme and the ureteric bud in wild type embryos
(S) and in the metanephric mesenchyme and the Wolffian duct in mutant embryos at this stage (T). The arrows point to the metanephric mesenchyme, and
the arrowheads point to either the ureteric bud in Gdf11/ or the Wolffian duct in Gdf11/ embryos. Note that in (C) and (K), the sections were cut at
a slightly skewed angle and include only one of two ureteric buds invading the metanephric mesenchyme. Abbreviations: m, metanephric mesenchyme; ub,
ureteric bud; wd, Wolffian duct. The scale bar represents 150 m.
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Because our in situ hybridization studies had shown that
Gdnf expression was absent in the uninvaded metanephric
mesenchyme of Gdf11 mutant embryos (Fig 3R), we tested
whether the addition of Gdnf protein to explants taken from
E11.5 Gdf11 null embryos could induce ureteric bud out-
growth from the mutant Wolffian ducts. The entire urogen-
ital system was dissected out of E11.5 Gdf11 mutant em-
bryos that clearly lacked ureteric bud formation and grown
in culture for 96 h on filter rafts in the presence or absence
of Gdnf protein (50 ng/ml). Explants were then stained with
DBA in order to visualize the Wolffian duct system and the
ureteric tree. In the absence of Gdnf protein, E11.5 Gdf11
mutant explants that lacked a ureteric bud at the time of
dissection, failed to form a ureteric bud after 96 h in culture
(Fig. 6C). As shown in Fig. 6D, multiple ureteric bud
structures were observed growing out along the Wolffian
duct of Gdf11 mutant embryos in the presence of Gdnf (6
out of 7 experiments). The frequency of ectopic ureteric bud
formation along the length of the Wolffian duct in Gdf11
mutant embryos was noted to be much more extensive when
Fig. 4. In situ detection of apoptosis in E11.5 and E12.5 Gdf11 homozygous mutant embryos defective in ureteric bud formation. Wild type (A, B, E, and
F) and Gdf11 mutant (C, D, and G–N) embryos at E11.5 (A–D) and E12.5 (E–N) were analyzed for apoptosis by using the TUNEL assay. Transverse sections
shown in (A, C, E, G and I) were stained with hematoxylin and eosin (H&E) for histological analysis. No increased apoptosis was detected at E11.5 (D) or
E12.5 (H) for Gdf11 mutant embryos in the area where kidney development should have taken place when compared with their wild type littermates (B, F).
However, sections taken from E12.5 Gdf11 mutant embryos just below the level of the developing gonads showed extensive apoptosis in the uninvaded
metanephric mesenchyme (J). The histological section in (I) shows the presence of metanephric mesenchyme that was not invaded by a ureteric bud. The
expression of metanephric mesenchyme-specific markers, Eya1 (K), Pax2 (L), and WT1 (M), confirmed the identity of this renal tissue. ActRIIB, a potential
receptor for Gdf11, was also expressed in the mutant metanephric mesenchyme undergoing apoptosis (N). The arrows in (I–N) point to the metanephric
mesenchyme in the E12.5 mutant embryos. Abbreviations: g, gonad; k, kidney; m, metanephric mesenchyme; ub, ureteric bud; wd, Wolffian duct. The scale
bar represents 200 m.
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compared with wild type cultures in the presence of Gdnf
protein (Fig. 6B and D), although the reason for this differ-
ence is unclear. These experiments demonstrate that the
Gdf11 mutant Wolffian ducts were competent to undergo
ureteric bud formation and the addition of Gdnf protein to
Gdf11 mutant kidney rudiments could rescue ureteric bud
outgrowth from the Wolffian duct. These results taken to-
gether with our in situ hybridization studies suggest that the
primary defect in Gdf11 mutant embryos is a lack of Gdnf
expression in the metanephric mesenchyme, which leads to
a failure of ureteric bud outgrowth from the Wolffian duct.
We also investigated whether the mutant metanephric
mesenchyme from Gdf11 null embryos that failed to form a
ureteric bud by E11.5 was competent to undergo later stages
of kidney development, specifically nephron formation.
Normally, the ureteric bud provides signals to the meta-
nephric mesenchyme that induce the mesenchyme to con-
dense and differentiate into nephron structures (Saxen,
1987). However, when E11.5 spinal cord is cultured to-
gether with separated E11.5 metanephric mesenchyme, the
spinal cord can substitute for the ureteric bud and induce the
renal tissue to undergo a similar tubulogenic program (Fig.
7A; Grobstein, 1955, 1956). To test whether mutant meta-
nephric mesenchyme isolated from E11.5 Gdf11 null em-
bryos defective in ureteric bud formation was competent to
undergo tubulogenesis, mutant Gdf11 mesenchyme was cul-
tured together with Gdf11 null spinal cord for 96 h on
nucleopore filter rafts. E11.5 Gdf11 null spinal cord was
used in these experiments to eliminate the contribution of
secreted Gdf11 protein to the cultures, since we had noted
during our original in situ hybridization analysis in wild
type embryos that Gdf11 was robustly expressed in the
dorsal half of the developing spinal cord (data not shown).
As shown in Fig. 7C, mutant metanephric mesenchyme was
capable of responding to the inductive signals from the
Gdf11 null spinal cord and forming tubules (5 out of 5
experiments) in a similar fashion as the control cocultures
(10 out of 11 experiments) (Fig. 7A). The metanephric
tubule structures formed in these experiments were visual-
ized by staining the cultures with an anti-laminin antibody,
which recognizes epithelialized tissue. These data confirm
that metanephric mesenchyme from homozygous null
Gdf11 embryos that failed to form a ureteric bud was com-
petent to undergo later stages of kidney development in-
volving nephron formation.
Activin type IIB receptor kidney expression patterns
The abnormalities in kidney development and in ante-
rior/posterior patterning of the axial skeleton seen in Gdf11
mutant embryos are strikingly similar to the abnormalities
reported in mice lacking the activin type IIB receptor
(ActRIIB) (Oh and Li, 1997; McPherron et al., 1999). The
similar phenotypes of these mutant mice, as well as recent
evidence showing that Gdf11 can bind to ActRIIB (Oh et
al., 2002), raise the possibility that Gdf11 uses ActRIIB for
cellular signaling during kidney development. We therefore
examined the expression patterns for ActRIIB during meta-
nephric organogenesis and compared these expression pat-
terns with those for Gdf11. In E10.5 wild type embryos,
ActRIIB mRNA was detected in the mesonephric tubules,
the Wolffian duct, and at low levels in the metanephric
mesenchyme that had not yet been invaded by a ureteric bud
(Fig. 2F and G). At E11.5, ActRIIB was expressed in both
the metanephric mesenchyme and the ureteric bud of the
developing kidney (Fig. 2H). By E12.5, ActRIIB expression
was detected both in the metanephric mesenchyme condens-
ing around the tips of the ureteric branches and in the
ureteric branches themselves (Fig. 2I; Feijen et al., 1994).
Robust expression of ActRIIB mRNA continued at E14.5 in
the developing ureter, the ureteric branches, the condensed
metanephric mesenchyme, and differentiating nephrons
(Fig. 2J). Therefore, ActRIIB mRNA patterns resembled
that of Gdf11 at early stages of kidney organogenesis with
both genes being expressed in the mesonephric tubules, the
Wolffian duct, the ureteric bud, and the metanephric mes-
enchyme (Fig. 2A–C and F–H). However, unlike ActRIIB,
Gdf11 was expressed in a population of uninduced meta-
nephric mesenchyme in the renal cortex and was expressed
at lower levels in the condensed metanephric mesenchyme
at E12.5 and E14.5 (Fig. 2D, E, I, and J). The findings that
Gdf11 and ActRIIB are essential for proper renal develop-
ment and are both expressed in the developing kidney are
consistent with the hypothesis that Gdf11 may use ActRIIB
for cellular signaling during kidney organogenesis.
We also investigated ActRIIB expression during meta-
nephric development in embryos lacking Gdf11. At E11.5,
ActRIIB expression was detected both in the Wolffian duct
and the metanephric mesenchyme of Gdf11 null embryos
that failed to form a ureteric bud (Fig. 3T). In a subset of
E11.5 mutant embryos exhibiting bilateral kidney develop-
ment, ActRIIB expression resembled that seen in wild type
embryos (data not shown). At E12.5 in Gdf11 null embryos,
ActRIIB expression was not detected in the area where the
kidney normally resides (data not shown), but transverse
sections taken posterior to the developing gonads in these
mutants showed expression of ActRIIB in the metanephric
mesenchyme undergoing extensive apoptosis (Fig. 4N).
These data show that, in Gdf11 mutant embryos, ActRIIB
continues to be expressed in the metanephric mesenchyme
and the Wolffian duct, although ureteric bud formation has
failed to occur.
Discussion
In the present study, we have shown that Gdf11 is im-
portant for kidney organogenesis. Although a subset of
mutant animals exhibited uni- or bilateral kidney develop-
ment, the majority of mice lacking Gdf11 had complete
renal agenesis. Analysis of the urogenital tracts of newborn
animals lacking Gdf11 revealed that the adrenal glands,
364 A.F. Esquela, S.-J. Lee / Developmental Biology 257 (2003) 356–370
male and female reproductive tracts, and bladder appeared
normal regardless of their kidney defects. Therefore, the
initial specification of the intermediate mesoderm during
embryogenesis appeared unperturbed, and rather abnormal-
ities appeared to be restricted to kidney development. More-
over, because the formation of the mesonephros proceeded
normally in mice lacking Gdf11, we conclude that this gene
specifically controls the formation of the definitive kidney,
the metanephros. Histological studies showed that the pri-
mary defect in most Gdf11 homozygous null animals ap-
peared to be a failure of ureteric bud outgrowth from the
Wolffian duct and the subsequent invasion of the ureteric
bud into the metanephric mesenchyme.
The expression of various kidney markers in the most
severely affected Gdf11 mutant embryos at E11.5 confirmed
that the Wolffian duct and the metanephric mesenchyme
had developed but that the mesenchyme was not competent
to induce ureteric bud formation and invasion into the neph-
ric mesenchyme. We noted that the Wolffian duct properly
expressed c-Ret, Emx2, Lim1, and Pax2, although the ure-
teric bud failed to form in the majority of null embryos
analyzed. Furthermore, Eya1, Pax2, Six2, and WT1 were
expressed in the uninvaded metanephric mesenchyme of
E11.5 Gdf11 null embryos, suggesting that the metanephric
mesenchyme had formed and begun to differentiate toward
a nephric lineage. However, Gdnf failed to be expressed in
Gdf11 mutant metanephric mesenchyme that was not in-
vaded by a ureteric bud. Gdnf has been shown to be a
metanephric mesenchyme-derived signal that binds to its
receptors, c-Ret and GFR1, in the posterior region of the
Wolffian duct and directs the formation of the ureteric bud
and its invasion into the mesenchyme (Schuchardt et al.,
1994, 1996; Enomoto et al., 1998). The majority of mice
homozygous null for Gdnf have a failure of ureteric bud
outgrowth (Moore et al., 1996; Pichel et al., 1996; Sanchez
et al., 1996). Gdnf is also important at later stages of kidney
development and induces further ureteric growth and
branching by binding to its receptors located at the tips of
the ureteric branches. Our expression studies suggest that
failure of the ureteric bud to form in the majority of Gdf11
null embryos may result from a lack of Gdnf signaling
between the metanephric mesenchyme and the posterior
portion of the Wolffian duct.
Metanephric mesenchyme from E12.5 Gdf11 mutant em-
bryos detected in regions posterior to the developing gonads
was shown by TUNEL analysis to undergo extensive apo-
ptosis. This nephric mesenchyme appropriately expressed
the kidney markers Eya1, Pax2, and WT1, confirming the
identity of this tissue. The marked increase of apoptosis in
this region was not surprising since it is believed that the
ureteric bud provides signals that promote the survival of
the metanephric mesenchyme as well as directs the conden-
sation and epithelization of the mesenchyme (Koseki et al.,
1992; Barasch et al., 1996). Transfilter organ culture exper-
iments in vitro have shown that E11.5 metanephric mesen-
chyme separated from the invaded ureteric bud will undergo
apoptosis and degenerate within 48 h in culture (Fig. 7B;
Saxen, 1987; Koseki et al., 1992). In addition, gene disrup-
tion studies for c-Ret, Eya1, Gdnf, and WT1 all report
increased apoptosis in the mutant metanephric mesenchyme
that was not invaded by the ureteric bud (Kreidberg et al.,
1993; Sanchez et al., 1996; Schuchardt et al., 1996; Xu et
al., 1999), similar to what we observed in Gdf11 mutant
embryos. We therefore conclude that the absence of ureteric
bud formation in most Gdf11 null embryos directly resulted
in the degeneration of the metanephric mesenchyme
through an apoptotic mechanism around E12.5.
Explant culture studies further suggest that the failure of
the metanephric mesenchyme to differentiate may result not
from the lack of Gdf11 signaling directly on this tissue but
rather as an indirect effect of the failure to form a ureteric
bud. When the metanephric mesenchyme was isolated from
E11.5 Gdf11 null embryos defective for ureteric bud for-
mation and grown together with dorsal spinal cord, a strong
inducer of tubulogenesis, the mutant tissue was capable of
forming condensates that went on to differentiate into
nephron-like structures. In this respect, the phenotype of
Gdf11 mutant embryos appears to be distinct from the
phenotypes of WT1 or Pax2 mutant embryos, which have
also been shown to have defects in ureteric bud outgrowth
(Kreidberg et al., 1993; Torres et al., 1995). Unlike Gdf11
mutant mesenchyme, WT1 or Pax2 mutant mesenchyme is
Fig. 5. Differentiation of whole E11.5 Gdf11 null kidney rudiments in explant culture. Urogenital tracts of E11.5 Gdf11/ and Gdf11/ embryos were
isolated and grown in culture for 120 h. The heterozygote kidney shown in (A) exhibited extensive growth and differentiation in culture, which was evident
by the well-formed ureteric tree stained with fluorescein-conjugated Dolichos biflorus–agglutinin (DBA). A kidney rudiment from a Gdf11 null littermate,
which clearly possessed a ureteric bud at the time of dissection, exhibited normal development in culture (B). However, the Gdf11/ kidney shown in (B)
appeared smaller in size when compared with the Gdf11/ kidney (A). Kidney rudiments isolated from Gdf11 null embryos that were devoid of ureteric
bud formation did not differentiate in culture (C), and a ureteric tree was never detected when the explants were stained with DBA after 120 h (data not
shown). The arrows in (A) and (B) indicate the differentiating kidney, and the black arrowhead in (C) indicates the position of the Wolffian duct. The scale
bars represent 250 m.
Fig. 6. Effect of Gdnf protein on kidney explants taken from E11.5 Gdf11 mutant embryos lacking a ureteric bud. E11.5 wild type (A, B) and Gdf11 mutant
(C, D) explants consisting of the Wolffian duct and the mesonephric and metanephric regions were cultured in the presence (B, D) or absence (A, C) of Gdnf
protein (50 ng/ml) for 96 h. Ectopic ureteric bud formation along the Wolffian duct was visualized by immunofluorescence staining using fluorescein-
conjugated Dolichos biflorus–agglutinin (DBA). Wild type urogenital explants cultured in the presence of Gdnf protein showed additional ectopic epithelial
buds growing out from the Wolffian duct as indicated by the arrowheads (B). Gdf11 mutant explants that clearly lacked a ureteric bud at the time of dissection
failed to differentiate in the absence of Gdnf protein (C). Gdf11 mutant explants grown in the presence of Gdnf protein showed extensive ectopic ureteric
bud formation along the Wolffian duct (D) when compared with the wild type in (B). Abbreviations: ub, ureteric bud; wd, Wolffian duct. The scale bar
represents 200 m.
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unable to form tubule structures when grown together with
dorsal spinal cord in culture (Kreidberg et al., 1993; Brophy
et al., 2001). Therefore, in contrast to both WT1 and Pax2,
which perform two independent roles during kidney forma-
tion, directing ureteric bud formation as well as inducing
tubulogenesis, Gdf11 appears to control ureteric bud out-
growth from the posterior portion of the Wolffian duct but
is not essential in later developmental events, such as tubule
formation.
Two possible mechanisms could explain the kidney de-
fects observed in the Gdf11 homozygous null mice. One
possibility is that these are secondary effects resulting from
the anterior/posterior patterning abnormalities present in
these embryos. We previously reported that all Gdf11 null
mice possessed anterior homeotic transformations of their
vertebral column, had posterior displacement of their hind
limbs, and showed alterations in Hox gene expression
within the prevertebrae (McPherron et al., 1999). Gdf11 has
also been shown to induce Hox gene expression in the chick
limb and in neural explants, which supports the idea that
Gdf11 works upstream of the Hox genes to control “posi-
tional identity” along the anterior/posterior axis (Gamer et
al., 1999; Liu et al., 2001). It is possible that the kidney
defects observed in the Gdf11 mutant embryos occurred due
to a misalignment of crucial tissues involved in kidney
formation along the body axis or a shift or a mistiming of
gene expression in the presumptive metanephric mesen-
chyme and/or Wolffian duct resulting in defective ureteric
bud formation.
In this respect, a recent report describing the disruption
of the Hox11 paralogous group in mice suggests that the
Hox genes are important for the proper patterning of the
kidney along the anterior/posterior axis (Wellik et al.,
2002). Specifically, the triple disruption of the Hox11
paralogous group resulted in ureteric bud defects and lack of
Gdnf expression in the mutant metanephric mesenchyme
similar to renal abnormalities observed in the Gdf11 mutant
mice. It has also been proposed that the Hox11 paralogues
work together with the Pax-Eya-Six network to pattern the
kidney since Hox11 triple mutants also do not express Six2
in the mutant metanephric mesenchyme, and therefore,
Hox11 defects resemble the renal abnormalities reported for
the Eya1 disruption (Xu et al., 1999).
For several reasons, we do not believe that the kidney
defects seen in the Gdf11 mutant embryos result from global
alterations in anterior/posterior patterning. First, our histo-
logical analysis and in situ hybridization studies of the
Gdf11 mutant embryos argue that both the Wolffian duct
and metanephric mesenchyme formed normally and ex-
pressed all kidney-specific markers appropriately with the
exception of Gdnf, suggesting that the original patterning of
the renal tissue was unperturbed. If the defects in kidney
Fig. 7. Analysis of tubule formation using Gdf11 mutant kidney rudiments. E11.5 metanephric mesenchyme was obtained from Gdf11/ (A, B) or Gdf11/
embryos defective in ureteric bud formation (C) and cultured next to E11.5 wild type (A) or Gdf11 mutant spinal cord (C) for 96 h. Gdf11 mutant metanephric
mesenchyme cultured next to mutant spinal cord showed similar epithelization of the mesenchyme observed in (A) confirming that the mutant metanephric
mesenchyme can respond to inductive signals (C). The presence of nephric tubules in (A) and (C) was confirmed by staining the explants with an anti-laminin
antibody (-lam) and then visualized by immunofluorescence. Wild type metanephric mesenchyme cultured alone for 96 h quickly degenerated (B) and was
negative for anti-laminin staining (data not shown). The arrows in (A–C) point to the metanephric mesenchyme. Abbreviation: sc, spinal cord. The scale bars
represent 200 m.
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development did result from misalignment of crucial tis-
sues, for example, one might have expected that expression
of more than a single kidney marker gene might have been
altered. Second, if Gdf11 worked upstream of the Hox11
genes during kidney organogenesis, we would predict that
Gdf11 homozygous mutants would also fail to express Six2
in their mutant metanephric mesenchyme, which is not the
case. Thus, Gdf11 may have an independent role in control-
ling ureteric bud formation that is unrelated from its role in
axial patterning.
We favor the possibility that Gdf11 plays a direct role
during the initial stage of metanephric kidney development
by inducing the expression of Gdnf in the metanephric
mesenchyme and thereby controlling ureteric bud out-
growth from the posterior region of the Wolffian duct. This
hypothesis is supported by in vitro studies in which we
added Gdnf protein to explant cultures that consisted of the
entire Wolffian duct system and the surrounding tissues
taken from both wild type and Gdf11 E11.5 null embryos.
We found that Gdf11 null cultures, which were devoid of
ureteric bud outgrowth at the time of dissection, were in-
duced by Gdnf protein to form numerous ectopic ureteric
buds along the Wolffian duct. The analysis of the wild type
expression patterns for Gdf11 during various stages of kid-
ney organogenesis further supports our hypothesis that
Gdf11 may regulate expression of Gdnf. We observed
Gdf11 expression in the mesonephros, the Wolffian duct,
and the metanephric mesenchyme at E10.5, prior to ureteric
bud formation. Gdnf is also expressed in the mesonephros
and the metanephric mesenchyme at this stage (Pichel et al.,
1996; Sanchez et al., 1996; Towers et al., 1998). Gdf11
mRNA was later detected in the metanephric mesenchyme
and the invading ureteric bud at E11.5, a time when Gdnf
mRNA is specifically localized to the metanephric mesen-
chyme (Pichel et al., 1996; Sanchez et al., 1996; Towers et
al., 1998). As kidney development progresses, Gdf11
mRNA becomes localized to the ureteric branches, to a
population of uninduced metanephric mesenchyme in the
renal cortex, and, to a lesser extent, to the condensed met-
anephric mesenchyme and differentiating nephrons. Like-
wise, Gdnf is expressed at later stages of kidney organo-
genesis, throughout the cortical region of the kidney and
most prominently in the condensed metanephric mesen-
chyme, but is downregulated in the differentiating nephric
tubules (Pichel et al., 1996; Sanchez et al., 1996; Towers et
al., 1998). Our in situ hybridization analysis shows that
Gdf11 is expressed early enough during kidney develop-
ment to direct ureteric bud outgrowth from the Wolffian
duct, possibly by regulating the expression of Gdnf in the
metanephric mesenchyme. However, based on our results, it
is not clear whether Gdf11 signaling is required in the
metanephric mesenchyme or the Wolffian duct in order to
regulate Gdnf expression and promote ureteric bud out-
growth. Furthermore, later expression patterns for Gdf11 in
the kidney suggest that Gdf11 may play multiple roles
during renal development.
During our analysis of Gdf11 null embryos, we observed
that a subset of mutant animals exhibited normal uni- or
bilateral kidney development. Histological studies revealed
that, if a ureteric bud formed in Gdf11 mutant mice, kidney
development appeared to progress in a normal fashion. In
situ analysis further showed that E11.5 Gdf11 mutant ani-
mals possessing a ureteric bud appropriately expressed all
of the kidney markers tested, including Gdnf. Kidney de-
velopment in this subset of Gdf11 mutant animals could
have been rescued either by a parallel pathway that controls
ureteric bud formation or by a redundant member of the
TGF superfamily. A number of genes have recently been
identified that are essential for ureteric bud outgrowth and
function upstream of Gdnf. These include the tumor sup-
pressor gene WTI (Kreidberg et al., 1993), the transcription
factors Eyal (Xu et al., 1999) and Pax2 (Torres et al., 1995),
and the Hox11 paralogous genes (Wellik et al., 2002).
Therefore, it is possible that there are several parallel path-
ways involved in directing the proper formation of the
ureteric bud that could rescue the Gdf11 phenotype. Another
possibility is that kidney development was rescued in a
subset of the Gdf11 mutant embryos by myostatin, which is
92% identical to Gdf11 within its C-terminal domain
(McPherron et al., 1999) and has been shown to bind to
ActRIIB, the presumptive receptor for Gdf11 (see below)
(Lee and McPherron, 2001; Oh et al., 2002). Analysis of
mice homozygous null for both Gdf11 and myostatin would
address the possibility of redundant function.
The abnormalities in axial skeleton patterning and kid-
ney development in Gdf11 mutant embryos are similar,
although more severe than the defects observed in embryos
mutant for a TGF type II serine/threonine kinase receptor,
activin receptor type IIB (ActRIIB) (Oh and Li, 1997;
McPherron et al., 1999). Specifically, ActRIIB-deficient
mice have anterior transformations of their spinal column,
including three extra thoracic vertebrae, and a spectrum of
kidney abnormalities, such as uni- or bilateral agenesis or
hypoplasia of both kidneys. Recent studies have also shown
that Gdf11 can bind to ActRIIB (Oh et al., 2002), which
raises the possibility that Gdf11 may use ActRIIB for cel-
lular signaling in the kidney. Therefore, we determined
whether ActRIIB is expressed at the appropriate time and in
the appropriate tissues during metanephric kidney develop-
ment in order to act as the receptor for Gdf11. We showed
that ActRIIB mRNA could be detected in the mesonephros,
the Wolffian duct, and the metanephric mesenchyme prior
to ureteric bud formation and in the metanephric mesen-
chyme and the invading ureteric bud at the initiation of
metanephric development in wild type embryos. ActRIIB
expression continued in these derivatives throughout kidney
organogenesis. Based on the expression patterns for
ActRIIB and Gdf11 within the developing kidney and the
similar disruption phenotypes for these genes, it is possible
that Gdf11 uses ActRIIB for cellular signaling during renal
organogenesis. However, the examination of the expression
patterns for Gdf11 and ActRIIB did not reveal which tissue,
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the metanephric mesenchyme or the Wolffian duct, was
responsible for the initial signal that induced the formation
of the ureteric bud.
Recent studies suggest that Gdf11 may, in addition to Ac-
tRIIB, use a related TGF type II serine/threonine kinase
receptor, activin receptor type IIA (ActRIIA), for cellular sig-
naling in the kidney. Gdf11 has been shown to bind to Ac-
tRIIA (Oh et al., 2002), and expression of this receptor has
been observed in the developing kidney (Feijen et al., 1994).
ActRIIA//ActRIIB/ mice possess severe anterior transfor-
mations of the vertebral column that closely resemble the axial
abnormalities observed in the Gdf11 null mice (McPherron et
al., 1999; Oh et al., 2002). Interestingly, 98% of ActRIIA//
ActRIIB/ animals showed kidney abnormalities compared
with only 25% observed in the ActRIIB null animals and 96%
observed for the Gdf11 mutant mice (McPherron et al., 1999;
Oh et al., 2002). These results imply that ActRIIA and Ac-
tRIIB share a redundant function in directing proper kidney
organogenesis, possibly by using Gdf11 as their ligand.
In summary, we have shown that Gdf11 plays an impor-
tant role in the initiation of metanephric development.
Based on the renal abnormalities observed in Gdf11 mutant
mice, we conclude that Gdf11 directs ureteric bud out-
growth from the Wolffian duct. Our in situ hybridization
studies and explant culture experiments suggest that Gdf11
signals through ActRIIB to control the expression of Gdnf
in the metanephric mesenchyme in order to induce ureteric
bud formation. To our knowledge, Gdf11 is the earliest
acting secreted factor identified to date in the molecular
pathway that controls metanephric organogenesis.
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